The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
Acquisitions have the potential to add at least $1 billion in sales by 2028
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
As a result, Imago will become a subsidiary of Merck.
Subscribe To Our Newsletter & Stay Updated
